Aetionomy: Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy
European Commission FP7-IMI-Seventh Framework Programme/Innovative Medicines Initiative
Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders
Today, diseases are defined largely on the basis of their symptoms, yet while two patients may share the same diagnosis, the underlying causes of their symptoms may be very different. This means that a treatment that works in one patient may prove ineffective in another. There is now broad recognition that a new approach to disease classification is needed, and that is where the AETIONOMY project comes in. It will pave the way towards a new approach to the classification of neurodegenerative diseases, particularly Alzheimers and Parkinsons diseases, thereby improving drug development and increasing patients chances of receiving a treatment that works for them.